These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30724092)

  • 1. The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes.
    Taber DJ; Ward R; Axon RN; Walker RJ; Egede LE; Gebregziabher M
    Ann Pharmacother; 2019 Jul; 53(7):675-682. PubMed ID: 30724092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident Diabetes.
    Gatwood JD; Chisholm-Burns M; Davis R; Thomas F; Potukuchi P; Hung A; Kovesdy CP
    J Manag Care Spec Pharm; 2018 Apr; 24(4):379-389. PubMed ID: 29578849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study.
    Moyo P; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Donohue JM; Hausmann LRM; Hanlon JT; Good CB; Fine MJ; Gellad WF
    Ann Intern Med; 2019 Apr; 170(7):433-442. PubMed ID: 30856660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual use of Department of Veterans Affairs and medicare benefits and use of test strips in veterans with type 2 diabetes mellitus.
    Gellad WF; Zhao X; Thorpe CT; Mor MK; Good CB; Fine MJ
    JAMA Intern Med; 2015 Jan; 175(1):26-34. PubMed ID: 25383920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Medication-Based Risk Adjustment on the Association Between Veteran Health Outcomes and Dual Health System Use.
    Radomski TR; Zhao X; Thorpe CT; Thorpe JM; Naples JG; Mor MK; Good CB; Fine MJ; Gellad WF
    J Gen Intern Med; 2017 Sep; 32(9):967-973. PubMed ID: 28462490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study.
    Carico R; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Hausmann LRM; Donohue JM; Suda KJ; Stroupe K; Hanlon JT; Good CB; Fine MJ; Gellad WF
    Ann Intern Med; 2018 Nov; 169(9):593-601. PubMed ID: 30304353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
    Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
    J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wide clinic-level variation in adherence to oral diabetes medications in the VA.
    Bryson CL; Au DH; Maciejewski ML; Piette JD; Fihn SD; Jackson GL; Perkins M; Wong ES; Yano EM; Liu CF
    J Gen Intern Med; 2013 May; 28(5):698-705. PubMed ID: 23371383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Reduced Drug Copayments on Adherence to Oral Diabetes Medications Among Childless Adults in Wisconsin Medicaid.
    Kim NH; Look KA
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1432-1441. PubMed ID: 31778619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?
    Kreyenbuhl J; Dixon LB; McCarthy JF; Soliman S; Ignacio RV; Valenstein M
    Schizophr Bull; 2010 Mar; 36(2):428-35. PubMed ID: 18718883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
    Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting medication adherence: patient perspectives from five veterans affairs facilities.
    Hsu C; Lemon JM; Wong ES; Carson-Cheng E; Perkins M; Nordstrom MS; Liu CF; Sprague C; Bryson CL
    BMC Health Serv Res; 2014 Nov; 14():533. PubMed ID: 25391694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose control and medication adherence among veterans with diabetes and serious mental illness: does collocation of primary care and mental health care matter?
    Long JA; Wang A; Medvedeva EL; Eisen SV; Gordon AJ; Kreyenbuhl J; Marcus SC
    Diabetes Care; 2014 Aug; 37(8):2261-7. PubMed ID: 24879839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Dual Use of Veterans Affairs and Medicare Part D Drug Benefits on Antihypertensive Medication Supply in a National Cohort of Veterans with Dementia.
    Thorpe CT; Gellad WF; Mor MK; Cashy JP; Pleis JR; Van Houtven CH; Schleiden LJ; Hanlon JT; Niznik JD; Carico RL; Good CB; Thorpe JM
    Health Serv Res; 2018 Dec; 53 Suppl 3(Suppl Suppl 3):5375-5401. PubMed ID: 30328097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
    Jing S; Naliboff A; Kaufman MB; Choy M
    J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes.
    Tan E; Yang W; Pang B; Dai M; Loh FE; Hogan P
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1195-202. PubMed ID: 26679968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of medication synchronization programs on proportion of days covered (PDC) scores and Medicare Part D medication-related adherence metrics.
    Bernard K; Cowles B; McCall K; Henningsen RM; O'Toole M; Tu C
    J Am Pharm Assoc (2003); 2019; 59(3):343-348. PubMed ID: 30940515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
    Cheong C; Barner JC; Lawson KA; Johnsrud MT
    Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.